Modulation by norepinephrine of neural responses to estradiol

M. E. Montemayor, A. S. Clark, D. M. Lynn, Edward J Roy

Research output: Contribution to journalArticle

Abstract

Pharmacological studies have suggested that neurotransmitter activity impinging on steroid-concentrating cells can affect the steroid receptor system within those cells, modifying behavioral responses to the hormone. The present experiments revealed that the α1-noradrenergic antagonist prazosin, administered to ovariectomized rats at the time of each of two pulses of estradiol, inhibited the appearance of sexual receptivity. Prazosin also substantially reduced the levels of estrogen receptors within hypothalamic cell nuclei following an injection of estradiol. Manipulation of noradrenergic inputs into the hypothalamus by lesioning brain stem norepinephrine cell groups with 6-hydroxydopamine (6OHDA) also reduced the level of nuclear estrogen receptors following an injection of estradiol. Although this effect of 6OHDA lesions was observed in two separate experiments, in other experiments 6OHDA had no effect on estrogen receptors. In some instances, there was a positive correlation between nuclear estrogen receptor levels in the hypothalamus and the levels of norepinephrine. The results are consistent with the hypothesis that brain stem inputs to the hypothalamus are able to modulate neural responses to steroids and specifically that noradrenergic inputs are able to modulate neural responses to estradiol. However, there are additional undiscovered variables that preclude statements of a simple relationship between norepinephrine levels and estrogen receptor levels.

Original languageEnglish (US)
Pages (from-to)473-480
Number of pages8
JournalNeuroendocrinology
Volume52
Issue number5
DOIs
StatePublished - Jan 1 1990

Fingerprint

Estrogen Receptors
Estradiol
Norepinephrine
Hypothalamus
Prazosin
Brain Stem
Steroids
Injections
Steroid Receptors
Oxidopamine
Cell Nucleus
Adrenergic Receptors
Neurotransmitter Agents
Stem Cells
Hormones
Pharmacology

Keywords

  • estrogen receptor
  • medial basal hypothalamus
  • norepinephrine
  • sexual behavior

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Endocrine and Autonomic Systems
  • Cellular and Molecular Neuroscience

Cite this

Modulation by norepinephrine of neural responses to estradiol. / Montemayor, M. E.; Clark, A. S.; Lynn, D. M.; Roy, Edward J.

In: Neuroendocrinology, Vol. 52, No. 5, 01.01.1990, p. 473-480.

Research output: Contribution to journalArticle

Montemayor, M. E. ; Clark, A. S. ; Lynn, D. M. ; Roy, Edward J. / Modulation by norepinephrine of neural responses to estradiol. In: Neuroendocrinology. 1990 ; Vol. 52, No. 5. pp. 473-480.
@article{33c8f28d9c294a30b57f8f7b2d8bc4d8,
title = "Modulation by norepinephrine of neural responses to estradiol",
abstract = "Pharmacological studies have suggested that neurotransmitter activity impinging on steroid-concentrating cells can affect the steroid receptor system within those cells, modifying behavioral responses to the hormone. The present experiments revealed that the α1-noradrenergic antagonist prazosin, administered to ovariectomized rats at the time of each of two pulses of estradiol, inhibited the appearance of sexual receptivity. Prazosin also substantially reduced the levels of estrogen receptors within hypothalamic cell nuclei following an injection of estradiol. Manipulation of noradrenergic inputs into the hypothalamus by lesioning brain stem norepinephrine cell groups with 6-hydroxydopamine (6OHDA) also reduced the level of nuclear estrogen receptors following an injection of estradiol. Although this effect of 6OHDA lesions was observed in two separate experiments, in other experiments 6OHDA had no effect on estrogen receptors. In some instances, there was a positive correlation between nuclear estrogen receptor levels in the hypothalamus and the levels of norepinephrine. The results are consistent with the hypothesis that brain stem inputs to the hypothalamus are able to modulate neural responses to steroids and specifically that noradrenergic inputs are able to modulate neural responses to estradiol. However, there are additional undiscovered variables that preclude statements of a simple relationship between norepinephrine levels and estrogen receptor levels.",
keywords = "estrogen receptor, medial basal hypothalamus, norepinephrine, sexual behavior",
author = "Montemayor, {M. E.} and Clark, {A. S.} and Lynn, {D. M.} and Roy, {Edward J}",
year = "1990",
month = "1",
day = "1",
doi = "10.1159/000125631",
language = "English (US)",
volume = "52",
pages = "473--480",
journal = "Neuroendocrinology",
issn = "0028-3835",
publisher = "S. Karger AG",
number = "5",

}

TY - JOUR

T1 - Modulation by norepinephrine of neural responses to estradiol

AU - Montemayor, M. E.

AU - Clark, A. S.

AU - Lynn, D. M.

AU - Roy, Edward J

PY - 1990/1/1

Y1 - 1990/1/1

N2 - Pharmacological studies have suggested that neurotransmitter activity impinging on steroid-concentrating cells can affect the steroid receptor system within those cells, modifying behavioral responses to the hormone. The present experiments revealed that the α1-noradrenergic antagonist prazosin, administered to ovariectomized rats at the time of each of two pulses of estradiol, inhibited the appearance of sexual receptivity. Prazosin also substantially reduced the levels of estrogen receptors within hypothalamic cell nuclei following an injection of estradiol. Manipulation of noradrenergic inputs into the hypothalamus by lesioning brain stem norepinephrine cell groups with 6-hydroxydopamine (6OHDA) also reduced the level of nuclear estrogen receptors following an injection of estradiol. Although this effect of 6OHDA lesions was observed in two separate experiments, in other experiments 6OHDA had no effect on estrogen receptors. In some instances, there was a positive correlation between nuclear estrogen receptor levels in the hypothalamus and the levels of norepinephrine. The results are consistent with the hypothesis that brain stem inputs to the hypothalamus are able to modulate neural responses to steroids and specifically that noradrenergic inputs are able to modulate neural responses to estradiol. However, there are additional undiscovered variables that preclude statements of a simple relationship between norepinephrine levels and estrogen receptor levels.

AB - Pharmacological studies have suggested that neurotransmitter activity impinging on steroid-concentrating cells can affect the steroid receptor system within those cells, modifying behavioral responses to the hormone. The present experiments revealed that the α1-noradrenergic antagonist prazosin, administered to ovariectomized rats at the time of each of two pulses of estradiol, inhibited the appearance of sexual receptivity. Prazosin also substantially reduced the levels of estrogen receptors within hypothalamic cell nuclei following an injection of estradiol. Manipulation of noradrenergic inputs into the hypothalamus by lesioning brain stem norepinephrine cell groups with 6-hydroxydopamine (6OHDA) also reduced the level of nuclear estrogen receptors following an injection of estradiol. Although this effect of 6OHDA lesions was observed in two separate experiments, in other experiments 6OHDA had no effect on estrogen receptors. In some instances, there was a positive correlation between nuclear estrogen receptor levels in the hypothalamus and the levels of norepinephrine. The results are consistent with the hypothesis that brain stem inputs to the hypothalamus are able to modulate neural responses to steroids and specifically that noradrenergic inputs are able to modulate neural responses to estradiol. However, there are additional undiscovered variables that preclude statements of a simple relationship between norepinephrine levels and estrogen receptor levels.

KW - estrogen receptor

KW - medial basal hypothalamus

KW - norepinephrine

KW - sexual behavior

UR - http://www.scopus.com/inward/record.url?scp=0025149520&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025149520&partnerID=8YFLogxK

U2 - 10.1159/000125631

DO - 10.1159/000125631

M3 - Article

C2 - 2177855

AN - SCOPUS:0025149520

VL - 52

SP - 473

EP - 480

JO - Neuroendocrinology

JF - Neuroendocrinology

SN - 0028-3835

IS - 5

ER -